{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:29:49Z","timestamp":1788218989287,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24591269"],"award-info":[{"award-number":["24591269"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sporadic inclusion body myositis (sIBM) is the most commonly acquired myopathy in middle-aged and elderly people. The muscle histology is characterized by both inflammation and degeneration, including sarcoplasmic aggregation of TDP-43. Cylindromatosis (CYLD) is a deubiquitinating enzyme that targets Lys63-linked ubiquitin chains and negatively regulates signal transduction pathways, such as NF-\u03baB signalling pathways. We examined localization of CYLD as well as phosphorylated TDP-43, phosphorylated p62, and Lys63-linked ubiquitin in muscle tissues of sIBM patients and muscle-specific wild-type TDP-43 transgenic (TDP-43 TG) mice. We investigated whether overexpression of CYLD can affect muscle toxicity in the cell models treated by endoplasmic reticulum (ER) stress inducers tunicamycin and thapsigargin. CYLD expressed with phosphorylated TDP-43, phosphorylated p62, and Lys63-linked ubiquitin in the nuclear and perinuclear regions of muscle fibres of wild-type TDP-43 TG mice and the degenerative myofibres of sIBM patients with rimmed vacuoles and endomysial cellular infiltration. Although expression levels of CYLD decreased and cell viability was reduced in cells treated with ER stress inducers, wild-type CYLD, but not the catalytic mutant, substantially improved cell viability based on the deubiquitinase activity. Dysregulation of CYLD may reinforce myodegeneration in the pathophysiology of sIBM by attenuating autophagic clearance of protein aggregates. Regulating CYLD in muscle fibres might serve as a novel therapeutic strategy for sIBM treatment.<\/jats:p>","DOI":"10.1038\/s41598-019-48115-2","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T10:03:02Z","timestamp":1565604182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["CYLD dysregulation in pathogenesis of sporadic inclusion body myositis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-3492","authenticated-orcid":false,"given":"Satoshi","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomu","family":"Tawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Nishikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"48115_CR1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00415-011-6185-8","volume":"259","author":"N Suzuki","year":"2012","unstructured":"Suzuki, N. et al. Increase in number of sporadic inclusion body myositis (sIBM) in Japan. J Neurol 259, 554\u2013556 (2012).","journal-title":"J Neurol"},{"key":"48115_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.55.2.296","volume":"55","author":"A Peng","year":"2000","unstructured":"Peng, A., Koffman, B. M., Malley, J. D. & Dalakas, M. C. Disease progression in sporadic inclusion body myositis: observations in 78 patients. Neurology 55, 296\u2013298 (2000).","journal-title":"Neurology"},{"key":"48115_CR3","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1093\/brain\/awr217","volume":"134","author":"FM Cox","year":"2011","unstructured":"Cox, F. M. et al. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain 134, 3167\u20133175 (2011).","journal-title":"Brain"},{"key":"48115_CR4","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/brain\/awr213","volume":"134","author":"O Benveniste","year":"2011","unstructured":"Benveniste, O. et al. Long-term observational study of sporadic inclusion body myositis. Brain 134, 3176\u20133184 (2011).","journal-title":"Brain"},{"key":"48115_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","volume":"37","author":"MC Dalakas","year":"2011","unstructured":"Dalakas, M. C. Review: An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 37, 226\u2013242 (2011).","journal-title":"Neuropathol Appl Neurobiol"},{"key":"48115_CR6","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.lpm.2010.11.024","volume":"40","author":"V Askanas","year":"2011","unstructured":"Askanas, V. & Engel, W. K. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-beta42 oligomers and phosphorylated tau. Presse Med 40, e219\u2013235 (2011).","journal-title":"Presse Med"},{"key":"48115_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","volume":"79","author":"CC Weihl","year":"2008","unstructured":"Weihl, C. C. et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79, 1186\u20131189 (2008).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"48115_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mus.21386","volume":"40","author":"M Salajegheh","year":"2009","unstructured":"Salajegheh, M. et al. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 40, 19\u201331 (2009).","journal-title":"Muscle Nerve"},{"key":"48115_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1365-2990.2012.01297.x","volume":"39","author":"S Yamashita","year":"2013","unstructured":"Yamashita, S. et al. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis. Neuropathol Appl Neurobiol 39, 406\u2013416 (2013).","journal-title":"Neuropathol Appl Neurobiol"},{"key":"48115_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.nmd.2016.12.009","volume":"27","author":"S Nakano","year":"2017","unstructured":"Nakano, S., Oki, M. & Kusaka, H. The role of p62\/SQSTM1 in sporadic inclusion body myositis. Neuromuscul Disord 27, 363\u2013369 (2017).","journal-title":"Neuromuscul Disord"},{"key":"48115_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9440(10)63089-1","volume":"164","author":"G Vattemi","year":"2004","unstructured":"Vattemi, G., Engel, W. K., McFerrin, J. & Askanas, V. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 164, 1\u20137 (2004).","journal-title":"Am J Pathol"},{"key":"48115_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.03668.x","volume":"96","author":"A Nogalska","year":"2006","unstructured":"Nogalska, A. et al. Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers. J Neurochem 96, 1491\u20131499 (2006).","journal-title":"J Neurochem"},{"key":"48115_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0304-3940(98)00657-0","volume":"254","author":"CC Yang","year":"1998","unstructured":"Yang, C. C., Askanas, V., Engel, W. K. & Alvarez, R. B. Immunolocalization of transcription factor NF-kappaB in inclusion-body myositis muscle and at normal human neuromuscular junctions. Neurosci Lett 254, 77\u201380 (1998).","journal-title":"Neurosci Lett"},{"key":"48115_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.expneurol.2006.12.014","volume":"204","author":"A Nogalska","year":"2007","unstructured":"Nogalska, A., Wojcik, S., Engel, W. K., McFerrin, J. & Askanas, V. Endoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis. Exp Neurol 204, 610\u2013618 (2007).","journal-title":"Exp Neurol"},{"key":"48115_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/76006","volume":"25","author":"GR Bignell","year":"2000","unstructured":"Bignell, G. R. et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25, 160\u2013165 (2000).","journal-title":"Nat Genet"},{"key":"48115_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nature01803","volume":"424","author":"E Trompouki","year":"2003","unstructured":"Trompouki, E. et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424, 793\u2013796 (2003).","journal-title":"Nature"},{"key":"48115_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/cdd.2009.43","volume":"17","author":"SC Sun","year":"2010","unstructured":"Sun, S. C. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ 17, 25\u201334 (2010).","journal-title":"Cell Death Differ"},{"key":"48115_CR18","doi-asserted-by":"publisher","first-page":"e17477","DOI":"10.1371\/journal.pone.0017477","volume":"6","author":"A Nagabhushana","year":"2011","unstructured":"Nagabhushana, A., Bansal, M. & Swarup, G. Optineurin is required for CYLD-dependent inhibition of TNFalpha-induced NF-kappaB activation. PLoS One 6, e17477 (2011).","journal-title":"PLoS One"},{"key":"48115_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1615\/CritRevImmunol.v29.i3.40","volume":"29","author":"K Wu","year":"2009","unstructured":"Wu, K. & Bonavida, B. The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29, 241\u2013254 (2009).","journal-title":"Crit Rev Immunol"},{"key":"48115_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.febslet.2009.12.051","volume":"584","author":"H Tang","year":"2010","unstructured":"Tang, H. et al. RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Lett 584, 662\u2013668 (2010).","journal-title":"FEBS Lett"},{"key":"48115_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2174\/1389450115666141024152421","volume":"16","author":"BJ Mathis","year":"2015","unstructured":"Mathis, B. J., Lai, Y., Qu, C., Janicki, J. S. & Cui, T. CYLD-mediated signaling and diseases. Curr Drug Targets 16, 284\u2013294 (2015).","journal-title":"Curr Drug Targets"},{"key":"48115_CR22","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1164\/rccm.201103-0447OC","volume":"184","author":"S Mitra","year":"2011","unstructured":"Mitra, S. et al. Role of growth arrest and DNA damage-inducible alpha in Akt phosphorylation and ubiquitination after mechanical stress-induced vascular injury. Am J Respir Crit Care Med 184, 1030\u20131040 (2011).","journal-title":"Am J Respir Crit Care Med"},{"key":"48115_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","volume":"129","author":"O Benveniste","year":"2015","unstructured":"Benveniste, O. et al. Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. Acta Neuropathol 129, 611\u2013624 (2015).","journal-title":"Acta Neuropathol"},{"issue":"779\u2013798","key":"48115_CR24","first-page":"vi","volume":"28","author":"MC Dalakas","year":"2002","unstructured":"Dalakas, M. C. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 28(779\u2013798), vi (2002).","journal-title":"Rheum Dis Clin North Am"},{"key":"48115_CR25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/ana.23840","volume":"73","author":"HB Larman","year":"2013","unstructured":"Larman, H. B. et al. Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann Neurol 73, 408\u2013418 (2013).","journal-title":"Ann Neurol"},{"key":"48115_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.23822","volume":"73","author":"H Pluk","year":"2013","unstructured":"Pluk, H. et al. Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis. Ann Neurol 73, 397\u2013407 (2013).","journal-title":"Ann Neurol"},{"key":"48115_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.24919","volume":"81","author":"N Tawara","year":"2017","unstructured":"Tawara, N. et al. Pathomechanisms of anti-cytosolic 5\u2032-nucleotidase 1A autoantibodies in sporadic inclusion body myositis. Ann Neurol 81, 512\u2013525 (2017).","journal-title":"Ann Neurol"},{"key":"48115_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.286","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang, S., Tang, M. B., Luo, H. Y., Shi, C. H. & Xu, Y. M. Necroptosis in neurodegenerative diseases: a potential therapeutic target. Cell Death Dis 8, e2905 (2017).","journal-title":"Cell Death Dis"},{"key":"48115_CR29","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cell.2008.10.044","volume":"135","author":"J Hitomi","year":"2008","unstructured":"Hitomi, J. et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135, 1311\u20131323 (2008).","journal-title":"Cell"},{"key":"48115_CR30","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/ncb2362","volume":"13","author":"MA O\u2019Donnell","year":"2011","unstructured":"O\u2019Donnell, M. A. et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 13, 1437\u20131442 (2011).","journal-title":"Nat Cell Biol"},{"key":"48115_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.expneurol.2018.08.006","volume":"309","author":"N Tawara","year":"2018","unstructured":"Tawara, N. et al. Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions. Exp Neurol 309, 169\u2013180 (2018).","journal-title":"Exp Neurol"},{"key":"48115_CR32","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","volume":"23","author":"MR Rose","year":"2013","unstructured":"Rose, M. R. & Group, E. I. W. 188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands. Neuromuscul Disord 23, 1044\u20131055 (2013).","journal-title":"Neuromuscul Disord"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48115-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48115-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48115-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:27:35Z","timestamp":1671280055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48115-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48115"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48115-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"12 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11606"}}